The Tema Cardiovascular and Metabolic ETF (HRTS) tracks companies involved in the treatment of cardio-metabolic diseases — a term that links cardiovascular diseases, obesity and diabetes.
Firms will have to be transparent, provide adequate guardrails and deliver impactful strategies to succeed because while AI won't replace humans it is not going away.
The SEC is expected, possibly by mid-January or sooner, to green-light ETFs that will buy and sell Bitcoin—after a decade of rejecting such applications.